• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Secret Regional Comprehensive Economic Partnership (RCEP) Takes Centre Stage In Asia

24/06/2015 by Patralekha Chatterjee for Intellectual Property Watch 4 Comments

The Trans-Pacific Partnership (TPP), part of US President Barack Obama’s promised pivot to Asia, has stirred up a hornet’s nest on the ethics of trying to hammer out a trade deal in secrecy. But it is not the only one. A proposed trade agreement in Asia, the Regional Comprehensive Economic Partnership (RCEP), is facing the same hiccups and flak.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Asia/Pacific, Copyright Policy, Development, Enforcement, English, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, WTO/TRIPS

Special Report: Will India Bend To US Pressure On IP Rights?

31/01/2015 by Patralekha Chatterjee for Intellectual Property Watch 5 Comments

It is no secret that the United States has been scaling up pressure on India to adopt intellectual property measures similar to those common in the United States and the European Union. But to what extent does India’s new government led by the business-friendly Narendra Modi see eye to eye with US official position? Can India, the “pharmacy of the world”, resolve the friction between pharmaceutical patents and access to affordable medicines without putting off foreign investors? The vitriolic and polarising debate surrounding these questions has got a fresh lease of life following US President Barack Obama’s landmark three-day visit to India this week.

While Indian and American business moguls are bullish about the future, Indian generic drug-makers as well as health activists within and outside India are deeply anxious about the shape of things to come

Filed Under: Features, IP Policies, Language, Themes, Access to Knowledge/ Education, Asia/Pacific, Copyright Policy, Development, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains

Will India, US Bridge Divide Over Intellectual Property Rights?

10/12/2014 by Patralekha Chatterjee for Intellectual Property Watch 4 Comments

There is an uptick in India-United States relations. US President Barack Obama will be in India in January as the chief guest at the country’s Republic Day Parade. Obama, who hosted India’s new Prime Minister Narendra Modi in Washington in September, will become the first US president to attend such a celebration, a display of India’s military might and ethnic diversity, as well as the first to visit India twice while in office.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Asia/Pacific, Copyright Policy, Development, English, Health & IP, Innovation/ R&D, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains

India’s IP Policy On Stage As Modi Heads To US

05/09/2014 by Patralekha Chatterjee for Intellectual Property Watch Leave a Comment

Will India’s new government bring in radical changes in the country’s intellectual property rights regime? That question has generated enormous buzz but no definitive answer ever since the Bharatiya Janata Party (BJP) swept to power with a decisive mandate in May this year.

[Update: the Indian government has announced that it has begun a process for a comprehensive IPR policy over the next six months, including a government think tank. See report here. The government website is here.]

Filed Under: IP Policies, Language, Themes, Venues, Asia/Pacific, Copyright Policy, English, Health & IP, North America, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains

Novartis Loses Patent Bid: Lessons From India’s 3(d) Experience

01/04/2013 by Patralekha Chatterjee for Intellectual Property Watch 15 Comments

New Delhi – On 1 April, in a packed room in India’s Supreme Court, two judges – Justice Aftab Alam and Justice Ranjana Desai – delivered a verdict that has the potential to dramatically change the national and global conversation about patents and patients.

Filed Under: Features, IP Policies, Language, Themes, Access to Knowledge/ Education, Asia/Pacific, Biodiversity/Genetic Resources/Biotech, Development, English, Europe, Health & IP, Human Rights, IP Law, Innovation/ R&D, Patents/Designs/Trade Secrets

Leaked IP Chapter Of India-EU FTA Shows TRIPS-Plus Pitfalls For India, Expert Says

12/03/2013 by Patralekha Chatterjee for Intellectual Property Watch 5 Comments

Indian negotiators are reportedly under tremendous pressure to give in to the European demands for a more rigid intellectual property rights regime in the ongoing discussions on EU-India free trade agreement, suggests a leaked draft text of the chapter on IP which is being negotiated.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Bilateral/Regional Negotiations, Copyright Policy, Development, Enforcement, English, Health & IP, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, Traditional and Indigenous Knowledge, WTO/TRIPS

India’s First Compulsory Licence Upheld, But Legal Fights Likely To Continue

04/03/2013 by Patralekha Chatterjee for Intellectual Property Watch 6 Comments

New Delhi – India’s Intellectual Property Appellate Board (IPAB) today upheld the country’s first compulsory licence on a pharmaceutical product. The much-awaited verdict by Justice (Ms) Prabha Sridevan upholds the compulsory licence issued to Hyderabad-based Natco Pharma Ltd, an Indian generic drug manufacturer, which sells a much cheaper version of German pharmaceutical company Bayer AG’s kidney and liver cancer drug Nexavar in the market.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Asia/Pacific, Development, Enforcement, English, Health & IP, IP Law, Patents/Designs/Trade Secrets, WTO/TRIPS

2013: India Battles For Right To Use Compulsory Licences To Make Medicines Affordable

22/01/2013 by Patralekha Chatterjee for Intellectual Property Watch Leave a Comment

India has started the New Year on a volatile note. With general elections looming in 2014, there is turbulence and not just in the political world. In India’s pharmaceutical industry, there is sparring over the prickly issue of ‘compulsory licenses’, a mechanism by which a government allows a domestic company to manufacture and sell a generic version of a patented drug without the consent of the patent-holder, who receives compensation.

Filed Under: IP Policies, Subscribers, Themes, Venues, Access to Knowledge/ Education, Asia/Pacific, Development, English, Health & IP, Human Rights, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

UN High-Level Meeting In India On Biodiversity Addresses Access And Benefit-Sharing

12/10/2012 by Patralekha Chatterjee for Intellectual Property Watch 1 Comment

At the ongoing 11th Conference of the Parties (COP11) to the United Nations Convention on Biological Diversity (CBD) in Hyderabad, the hot topic is funds and how to mobilize it. The mega-conference is taking place in the shadow of a global economic slowdown, and delegates gathered at this southern Indian city are most concerned about how to drum up funds to tackle the world’s shrinking biodiversity – the variety of animal and plant life on earth.

Filed Under: Features, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Biodiversity/Genetic Resources/Biotech, Development, Enforcement, English, Human Rights, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, Traditional and Indigenous Knowledge, United Nations - other

India: Balancing Public And Private Interests In The Intellectual Property Regime

18/09/2012 by Patralekha Chatterjee for Intellectual Property Watch 5 Comments

NEW DELHI – In this month, there have been two court orders in India that underscore the complexities underlying the country’s intellectual property regime. Last Friday (14 September), the Chennai-based Intellectual Property Appellate Board (IPAB) which is responsible for hearing appeals on patent applications, rejected a petition by German pharma major Bayer AG, seeking a stay on an order of India’s Controller of Patents granting a compulsory licence (CL) to Indian generic drug maker Natco Pharma Limited, for a drug used to treat liver and kidney cancer.

Filed Under: Features, IP Policies, Language, Themes, Access to Knowledge/ Education, Asia/Pacific, Development, Enforcement, English, Health & IP, Human Rights, IP Law, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer

  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting